Tradestie Institutional Equity Comparison Engine
BCAX vs MGTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MGTX Overall Edge
MGTX Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MeiraGTx Holdings plc Ordinary Shares (MGTX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BCAX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MGTX at 64.1x Forward P/E and 44.8% operating margin (+1074.1% YoY). In options structure, BCAX sits in BREAKDOWN (23rd %ile IV; Dealer Gamma Walls on Pro) against MGTX sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MGTX
BCAX N/M vs MGTX 64.1x Fwd P/E
Growth & Margin Winner
MGTX
Op Margin 0.0% vs 44.8% ยท YoY +0.0% vs +1074.1%
Momentum & Technical Winner
MGTX
1Y -31.6% vs +5.8% ยท 52W Pos 8% vs 24%
Options & Structure Winner
MGTX
BREAKDOWN (23rd %ile IV) vs BREAKDOWN (3rd %ile IV)
BCAX
NASDAQ
Bicara Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$9.75
-2.69% 1D
Market Cap
$665.2M
1M Return
-41.9%
1Y Return
-31.63%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 58.0
Fund 66.0
Flow 68.0
Mom 64.0
MGTX
NASDAQ
MeiraGTx Holdings plc Ordinary Shares
Biological Products, (No Disgnostic Substances)
$8.74
-4.79% 1D
Market Cap
$897.2M
1M Return
-5.82%
1Y Return
+5.81%
Forward P/E
64.1x
Unified AI Score
43.7 / 100
HOLD
Tech 33.0
Fund 58.0
Flow 70.0
Mom 58.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BCAX -31.63%
MGTX +5.81%
Spread: +37.44 pp (MGTX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BCAX TTM Op. Margin: 0.0%
MGTX TTM Op. Margin: 44.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BCAX vs MGTX. Trailing 12-month operating profitability (BCAX 0.0% vs MGTX 44.8%) and valuation multiples (BCAX N/M vs MGTX 64.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BCAX | MGTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $665.2M | $897.2M | Larger Scale | MGTX |
| Trailing P/E Ratio Valuation | N/M | 10.6x | Lower Multiple | MGTX |
| Forward P/E Ratio Valuation | N/M | 64.1x | Lower Multiple | MGTX |
| Revenue Growth (YoY) Growth | +0.0% | +1074.1% | Higher Growth | MGTX |
| Operating Margin (TTM) Profitability | 0.0% | 44.8% | Higher Margin | MGTX |
| Net Profit Margin Profitability | 0.0% | 19.5% | Higher Margin | MGTX |
| Return on Equity (ROE) Capital Efficiency | -54.2% | 89.5% | Higher ROE | MGTX |
| 52-Week Range Position Momentum | 8% ($8โ$31) | 24% ($7โ$15) | Stronger Trend | MGTX |
| Beta / 30D Volatility Risk Regime | 1.42ฮฒ ยท 184% Vol | 1.66ฮฒ ยท 69% Vol | Lower Realized Risk | MGTX |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 43.7 / 100 (HOLD) | Higher Composite | BCAX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BCAX vs MGTX Buy Guide
BCAX
BREAKDOWN
93d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
23rd %ile
IV Regime
Compressed (<25th %ile)
MGTX
BREAKDOWN
62d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BCAX nor MGTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.